Search the Site
Follow TheCancerLetter on Twitter
join our mailing list

Enter your name and email address to receive an update when we post new content.

IP Login

 

The Cancer Letter Inc.
PO Box 9905
Washington
DC 20016
Tel: 202-362-1809
Fax: 202-379-1787
publication date: Jun 17, 2016
ISSUE 24 - June 17, 2016 PDF



Moonshot May Play Role in $400 Million Annual Contract to Run NCI's Frederick Lab

The contract for operations and technical support at the Frederick National Laboratory for Cancer Research could be accepting proposals as early as next month—but NCI advisors said they are hoping to slow the recompetition process to reform the laboratory’s mission.

Moreover, NCI should consider how the laboratory could contribute to Vice President Joe Biden’s National Cancer Moonshot Initiative, members of the Frederick National Laboratory Advisory Committee said at a recent meeting.

Task Force Adds Tests to Colon Screening Guideline

The final version of guidelines for colorectal cancer screening by the U.S. Preventive Services Task Force differ substantively from the group’s draft version published last October.

The final version—unlike the draft—lists CT colonography and FIT-DNA as screening methods that are equal to others.

It’s unclear whether political pressure had any role in prompting the panel to broaden its list of detection strategies from three to seven in the past six months.

Conversation with The Cancer Letter

Guideline Edits Rooted in Science, Former USPSTF Member Says

"I don’t see this recommendation as differing in any substantial way from some others that we’ve made, where we suggested that patients talk with their clinicians, and the important messages here is that colorectal cancer screening works, that colorectal cancer screening reduces deaths from colorectal cancer,” said Douglas Owens, a who has rotated off the U.S. Preventive Services Task Force, and was involved in developing the colorectal cancer screening guideline published earlier this week.

In Brief
  • President Obama names six appointees to the NCAB
  • Stand Up to Cancer to host fifth-biennial televised fundraiser

  • Kety Duron joins City of Hope as chief human resources officer

  • Miami Cancer Institute takes delivery of 220-ton proton therapy cyclotron

  • Takeda and M2Gen to collaborate on ORIEN genomic data

  • Mayo Clinic and Kiyatec to collaborate on ovarian cancer care

  • St. Jude receives pathology accreditation through College of American Pathologists

Drugs and Targets
  • Canadian review agency delivers positive opinion for Opdivo in NSCLC
  • Genomic Health launches Oncotype SEQ Liquid Select biopsy test

 


Copyright (c) 2016 The Cancer Letter Inc.

Letter